HIV/AIDS Topics Preventive and Therapeutic HIV Vaccine Data Presented at AIDS Vaccine 2011
- Details
- Category: HIV Vaccines
- Published on Monday, 19 September 2011 00:00
- Written by Liz Highleyman
The AIDS Vaccine 2011 conference, which concluded last week in Bangkok, brought together more than 800 researchers, public health officials, advocates, and others to hear the latest findings on vaccines intended to prevent HIV infection and control disease progression.
AIDS Vaccine Conference Underway in Bangkok
- Details
- Category: HIV Vaccines
- Published on Monday, 12 September 2011 00:00
- Written by Global HIV Vaccine Enterprise
AIDS Vaccine 2011, an international conference sponsored by the Global HIV Vaccine Enterprise, is taking place this week in Bangkok, Thailand. The annual AIDS vaccine meeting is the major dedicated venue for research related to immune response against HIV and its translational into effective preventive vaccine candidates. 
HIV Vaccine Development Remains Challenging, but Holds Promise
- Details
- Category: HIV Vaccines
- Published on Friday, 09 September 2011 00:00
- Written by NIH
The "holy grail" of HIV research -- a protective vaccine -- has eluded scientists for the past 3 decades. But various approaches for inducing broadly neutralizing antibodies against the virus have made progress.
"We are optimistic that the tools of modern science will enable us to develop HIV vaccines that induce effective immune responses that do better than natural immunity and prevent HIV infection," Margaret Johnston and Anthony Fauci from the National Institute of Allergy and Infectious Diseases write in the September 8, 2011, New England Journal of Medicine.
Gene Therapy Protects Cat Cells against Feline Immunodeficiency Virus
- Details
- Category: HIV Vaccines
- Published on Monday, 12 September 2011 00:00
- Written by Mayo Clinic
Using a genome modification technique that inserts a macaque monkey restriction factor plus a fluorescent tracer into cat cells, researchers at the Mayo Clinic in Rochester, MN, were able to protect the cells from infection with feline immunodeficiency virus -- an approach that may shed light on ways to protect human cells from HIV infection. Findings were reported in the September 11, 2011, online edition of Nature Methods.
Many Gay Men Interested in PrEP, Experts Create Road Map
- Details
- Category: HIV Prevention
- Published on Tuesday, 06 September 2011 00:00
- Written by Liz Highleyman
Nearly half of U.S. gay/bisexual men said they would be "very likely" to use antiretroviral drugs as pre-exposure prophylaxis (PrEP) if it significantly reduces the risk of HIV infection. Another recent study explored the effect of PrEP on condom use. These findings further inform the sometimes contentious debate about how effective PrEP will be in "real world" use, whether benefits outweigh risks, and how to provide access.
More Articles...
- Highlights from the National HIV Prevention Conference
- Large Vaccine Study Will Look at HIV Prevention as well as Disease Progression
- IAS 2011: Hormonal Contraceptive Use Increases Women’s Risk of Acquiring and Transmitting HIV
- IAS 2011: Final iPrEX Analysis Confirms PrEP Effectiveness for Gay Men
Web Design and Development by